International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8347445
Original Article
Colour Doppler Evaluation of Erectile Dysfunction in Tertiary Care Centre
 ,
 ,
 ,
 ,
Published
Sept. 14, 2023
Abstract

Background: Erectile dysfunction (ED) is a widespread health issue affecting men across different age groups. Its complexity arises from the interaction of arterial, venous, sinusoidal, and nervous systems, with dysfunctions leading to ED. Various factors, such as cardiovascular diseases, diabetes, and lifestyle habits, influence ED. Penile Doppler sonography, a non-invasive method, is instrumental in evaluating ED, offering insights into penile anatomy and vascular flow patterns.

Objectives: To assess the diverse causes of Erectile Dysfunction using Colour Doppler in a tertiary care center.

Materials and Methods: In a prospective observational study from March 2021 to August 2022, 45 patients clinically diagnosed with ED were referred from various departments to the Department of Radio-Diagnosis, Vydehi Institute of Medical Sciences and Research Centre. Evaluation involved an intracavernosal injection of papaverine, followed by peak systolic and EDV measurements in the right cavernosal artery at 5-minute intervals for 30 minutes.

Results: Colour Doppler ultrasound effectively diagnosed ED by showcasing arterial and venous insufficiencies. Systolic velocities below 25cm/s indicated arterial insufficiency, while an EDV over 5cm/s denoted venous incompetence. The method is likely to undergo further refinement in the diagnostic criteria.

Conclusion: Penile Doppler ultrasound emerges as a secure, minimally invasive, and efficient method for evaluating ED. It offers a fast and straightforward assessment, making it a preferred choice in clinical settings.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
23 Views
286 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved